UF Health Durbin Park is preparing to bring hospital care, emergency services, and advanced specialties closer to communities across Northeast Florida
St. Johns County, Florida, 17 August 2026 - Healthcare access in the Jacksonville area is set to expand with...
The animal health company is expanding its pipeline across obesity, cancer, chronic kidney disease, cardiology, anxiety, and other areas of unmet need
Parsippany, New Jersey, 10 August 2026 – Zoetis is strengthening its focus on next-generation animal healthcare as it...
New regulatory program aims to expand patient access to innovative digital health devices while gathering real-world evidence to support future healthcare decisions
Silver Spring, Maryland, 27 July 2026 – The U.S. Food and Drug Administration has selected Dexcom as the...
BurnTide Introduces a New Dietary Supplement as Consumer Interest in Everyday Wellness Continues to Grow
New York City, 20 July 2026 – The health and wellness industry continues to expand as consumers increasingly seek products that support healthy lifestyles. Joining...
The Global Oncology Crisis: A Systemic Turning Point
Cancer control has reached a critical juncture worldwide. According to global epidemiological estimates, over 19.3 million new cancer cases are diagnosed annually, generating an unprecedented human and economic burden across every continent....
Leadership is particularly critical in complex and high-need domains, such as oncology. Research hospitals guided by a general manager with close support respectively from the healthcare and administrative directors tipically feature also a vision promoted by their scientific directors....
Across more than three decades in medicine, cancer biology, global health, and biopharmaceutical R&D, Dr. Oscar L. Kashala has worked where scientific discovery meets clinical development and patient care. That trajectory has shaped a perspective relevant to oncology strategy:...
Cancer presents medicine with a fundamental biological problem: two patients diagnosed with the same cancer may not, at the molecular level, have the same disease.
Their tumors can carry different mutations, produce different antigens and respond differently to treatment. Even...
